179 related articles for article (PubMed ID: 16380629)
21. [Anti-muscle-specific tyrosine kinase (MuSK) antibody].
Ohta M; Ohta K; Shigemoto K; Shimoda Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():633-6. PubMed ID: 20942150
[No Abstract] [Full Text] [Related]
22. Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.
Bhatt A; Farooq MU; Chang HT
Onkologie; 2011; 34(7):382-3. PubMed ID: 21734425
[No Abstract] [Full Text] [Related]
23. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
[TBL] [Abstract][Full Text] [Related]
24. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
[No Abstract] [Full Text] [Related]
25. MuSK-positive myasthenia gravis is rare in the Polish population.
Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H
Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794
[TBL] [Abstract][Full Text] [Related]
26. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
Guptill JT; Sanders DB; Evoli A
Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
[TBL] [Abstract][Full Text] [Related]
27. Familial autoimmune MuSK positive myasthenia gravis.
Corda D; Deiana GA; Mulargia M; Pirastru MI; Serra M; Piluzza MG; Carcassi C; Sechi G
J Neurol; 2011 Aug; 258(8):1559-60. PubMed ID: 21369718
[No Abstract] [Full Text] [Related]
28. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
Chan KH; Lachance DH; Harper CM; Lennon VA
Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
[TBL] [Abstract][Full Text] [Related]
29. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
[TBL] [Abstract][Full Text] [Related]
30. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
31. Paroxysmal supraventricular tachycardia in anti-musk Myasthenia gravis: A case report.
Di Giovanni M; Battisti C; Salvatore S; Tumminelli G; Vinciguerra C; Ruocco G; Federico A
J Neurol Sci; 2016 Oct; 369():250-251. PubMed ID: 27653899
[No Abstract] [Full Text] [Related]
32. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
33. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
Bhibhatbhan A; Kline G; Vincent A; Toth C
Muscle Nerve; 2007 Aug; 36(2):264-6. PubMed ID: 17266132
[TBL] [Abstract][Full Text] [Related]
34. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
[TBL] [Abstract][Full Text] [Related]
35. AChR-and MuSK-positive myasthenia gravis: Double trouble.
Zouvelou V; Psimenou E
J Neuroimmunol; 2020 Nov; 348():577364. PubMed ID: 32916523
[TBL] [Abstract][Full Text] [Related]
36. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Saka E; Topcuoglu MA; Akkaya B; Galati A; Onal MZ; Vincent A
Neurology; 2005 Sep; 65(5):782-3; author reply 782-3. PubMed ID: 16157930
[No Abstract] [Full Text] [Related]
37. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
38. Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia.
Spengos K; Vassilopoulou S; Papadimas G; Tsivgoulis G; Karandreas N; Zambelis T; Manta P
Neuromuscul Disord; 2008 Feb; 18(2):175-7. PubMed ID: 18053719
[TBL] [Abstract][Full Text] [Related]
39. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
Bau V; Hanisch F; Hain B; Zierz S
Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
